A former Abbott Vascular medical liaison alleges that the company fired her after she flagged Abbott for off-label promotion of its Xience stent and pre-approval marketing of its bioresorbable vascular scaffold.
Edwards Lifesciences affirms its outlook for 2014 and reveals its 2015 guidance, along with an increased investment in CardioKinetix and a new leader for its critical care business lured from Medtronic.
Direct Flow Medical says it raised a $32 million funding round and tapped medtech veteran Chris Richardson to be its new chief commercial officer.
Direct Flow Medical said today that it landed a $32 million funding round for its replacement heart valve technology and tapped a 25-year medical device veteran, Chris Richardson, to lead its commercialization program.
RBC is also the exclusive provider of AdvantageRF - a portfolio of flexible mix and match solution tools for RF product developers that reduce risks, enhance reliability and sustainability, as well as accelerate time to market and lower R & D costs.